A Multicenter, Open-Label, Single-Arm Study to Evaluate the Single-Dose Pharmacokinetics, Acceptability and Safety of Famciclovir Oral Pediatric Formulation in Infants 1 Month to Less Than 1 Year of Age With Herpes Simplex Virus Infections.

Trial Profile

A Multicenter, Open-Label, Single-Arm Study to Evaluate the Single-Dose Pharmacokinetics, Acceptability and Safety of Famciclovir Oral Pediatric Formulation in Infants 1 Month to Less Than 1 Year of Age With Herpes Simplex Virus Infections.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Famciclovir (Primary)
  • Indications Herpes simplex virus infections
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 13 Mar 2009 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 30 Oct 2008 Planned end date changed from 1 Oct 2008 to 1 Nov 2008, based on information from ClinicalTrials.gov.
    • 30 Oct 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top